Northern Capital Management, Inc. Abbott Laboratories Transaction History

Northern Capital Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	SELL	$95.53 - $114.62 $4,394 - $5,272	-46 Reduced 2.07%	2,177 $210,000
Q2 2023 Jul 27, 2023	BUY	$100.78 - $112.29 $100 - $112	1 Added 0.05%	2,223 $242,000
Q1 2023 May 08, 2023	BUY	$96.86 - $114.01 $96 - $114	1 Added 0.05%	2,222 $224,000
Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $95 - $111	1 Added 0.05%	2,221 $243,000
Q3 2022 Oct 24, 2022	BUY	$96.76 - $112.03 $96 - $112	1 Added 0.05%	2,220 $215,000
Q2 2022 Aug 02, 2022	BUY	$102.07 - $123.37 $102 - $123	1 Added 0.05%	2,219 $241,000
Q1 2022 Apr 26, 2022	BUY	$114.02 - $139.04 $114 - $139	1 Added 0.05%	2,218 $263,000
Q3 2021 Oct 13, 2021	BUY	$116.66 - $129.06 $5,599 - $6,194	48 Added 2.21%	2,217 $262,000
Q2 2021 Jul 16, 2021	SELL	$105.79 - $124.53 $2,538 - $2,988	-24 Reduced 1.09%	2,169 $251,000
Q1 2021 May 04, 2021	BUY	$108.84 - $128.23 $2,829 - $3,333	26 Added 1.2%	2,193 $263,000
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $227,535 - $247,948	2,167 New	2,167 $237,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Northern Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Northern Capital Management, Inc. with notifications on news.